Hardin Capital Partners’s Pfizer PFE Stock Holding History

Hardin Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Sell	9,476 -968	-9%	-$25.3K	0.11%	125
2026 Q1	$293K	Buy	10,444 +204	+2%	+$5.43K	0.14%	100
2025 Q4	$255K	Buy	10,240 +537	+6%	+$13.5K	0.12%	109
2025 Q3	$247K	Hold	9,703	–	–	0.13%	100
2025 Q2	$243K	Sell	9,703 -567	-6%	-$13.2K	0.14%	99
2025 Q1	$260K	Buy	10,270 +314	+3%	+$8.22K	0.16%	97
2024 Q4	$264K	Buy	9,956 +33	+0.3%	+$895	0.16%	93
2024 Q3	$290K	Buy	9,923 +823	+9%	+$24K	0.16%	92
2024 Q2	$255K	Buy	+9,100	New	+$251K	0.17%	96

Other funds holding PFE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hardin Capital Partners's PFE Position: Q2 2026 in Review

Hardin Capital Partners reduced its Pfizer (PFE) stake by 9.3% in Q2 2026, selling an estimated $25.3K and leaving 9,476 shares worth $229K. The position accounts for 0.11% of the portfolio, ranked #125.

Hardin Capital Partners first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $293K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Hardin Capital Partners held 9,476 shares of Pfizer worth $229K as of Q2 2026.
Hardin Capital Partners sold 968 Pfizer shares in Q2 2026, an estimated $25.3K.
Pfizer made up 0.11% of Hardin Capital Partners's portfolio in Q2 2026, its #125 holding.
Hardin Capital Partners first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Hardin Capital Partners's Pfizer position peaked at $293K in Q1 2026.
1,694 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hardin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.